Gregory Glenn Selected Research

asparaginyl-proline

1/2021

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory Glenn Research Topics

Disease

5	Infections 01/2019 - 02/2016
4	COVID-19 12/2023 - 11/2020
3	Respiratory Tract Infections (Respiratory Tract Infection) 02/2021 - 01/2019
2	Malaria 12/2022 - 01/2021
2	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2020 - 02/2016
2	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2016
2	Diarrhea 01/2017 - 03/2002
2	Human Influenza (Influenza) 07/2015 - 10/2011
1	Virus Diseases (Viral Diseases) 01/2021
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2021
1	Respiratory Syncytial Virus Infections 12/2018
1	Fever (Fevers) 04/2016
1	Influenza in Birds (Avian Flu) 07/2015

Drug/Important Bio-Agent (IBA)

14	VaccinesIBA 12/2022 - 03/2002
5	AntibodiesIBA 12/2022 - 01/2016
4	Matrix-MIBA 12/2023 - 01/2021
3	NVX-CoV2373 adjuvated lipid nanoparticleIBA 12/2023 - 01/2021
3	Subunit VaccinesIBA 12/2023 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2019 - 12/2018
1	SaponinsIBA 12/2023
1	Rabies Vaccines (Rabies Vaccine)FDA Link 12/2022
1	rabivaxIBA 12/2022
1	asparaginyl-prolineIBA 01/2021
1	AntigensIBA 01/2021
1	Palivizumab FDA Link 12/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	Neutralizing AntibodiesIBA 02/2016
1	hippuryl-glycyl-glycine (HIGG)IBA 02/2016
1	EpitopesIBA 07/2015
1	AntitoxinsIBA 03/2002